Table 4.
Comparison of Whether Cannabigerol-Predominant Cannabis or Conventional Medications Are Reported More Effective or Equally Effective
| Medical condition | n | CBG,% | Conventional medication, % | Equivalent, % | Chi-square value | p |
|---|---|---|---|---|---|---|
| Anxiety | 60 | 78.3a | 11.7b | 10.0b | 54.70 | <0.001 |
| Chronic pain | 46 | 73.9a | 13.0b | 13.0b | 34.09 | <0.001 |
| Depression | 40 | 80.0a | 20.0b | 20.0b | 39.20 | <0.001 |
| Insomnia/disturbed sleep | 37 | 73.0a | 10.8b | 16.2b | 26.32 | <0.001 |
| Migraine/headache | 22 | 59.1a | 13.6b | 27.3ab | 7.18 | 0.03 |
| Other inflammatory problems | 22 | 86.4a | 4.5b | 9.1b | 27.91 | <0.001 |
| Acute pain | 19 | 68.4a | 15.8b | 15.8b | 10.53 | 0.005 |
| Nausea | 17 | 76.55a | 5.9b | 17.6b | 14.59 | <0.001 |
| Irritable bowel syndrome | 17 | 82.4a | 11.8b | 5.9b | 18.47 | <0.001 |
| Cancer treatment | 7 | 57.1 | 14.3 | 28.6 | 2.00 | 0.37 |
| Autoimmune disease | 9 | 77.8a | 0b | 22.2ab | 8.67 | 0.01 |
| Bacterial infection/antibiotic | 7 | 57.1 | 14.3 | 28.6 | 2.00 | 0.37 |
| High blood pressure | 8 | 50.0 | 0 | 50.0 | 4.00 | 0.14 |
| Osteoarthritis | 6 | 16.7a | 16.7a | 66.7b | 13.00 | 0.002 |
| Menstrual cramps | 6 | 33.3 | 16.7 | 50.0 | 1.00 | 0.61 |
| Premenstrual syndrome | 5 | 80.0 | 0 | 20.0 | 5.20 | 0.07 |
| Crohn's/ulcerative colitis | 4 | 75.0 | 0 | 25.0 | 3.50 | 0.17 |
| Glaucoma | 3 | 33.3 | 0 | 66.7 | 2.00 | 0.37 |
| Fibromyalgia | 7 | 85.7 | 0 | 14.3 | 8.86 | 0.01 |
| Cancer treatment-related symptoms | 3 | 66.7 | 33.3 | 0 | 2.00 | 0.37 |
| Menopausal symptoms | 3 | 66.7 | 0 | 33.3 | 2.00 | 0.37 |
| Seizures/epilepsy | 3 | 66.7 | 0 | 33.3 | 2.00 | 0.37 |
| Endometriosis | 3 | 66.7 | 33.3 | 0 | 2.00 | 0.37 |
| Rheumatoid arthritis | 3 | 66.7 | 0 | 33.3 | 2.00 | 0.37 |
| Multiple sclerosis | 1 | 100 | 0 | 0 | ||
| Premenstrual dysphoric disorder | 1 | 100 | 0 | 0 |
Percentages that share a superscript are not significantly different, while those that have different superscript letters are significantly different at p<0.05.